Sodium borate

Last content change Sep 28, 2021checked dailysee data sync status

DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Active ingredient: Sodium Borate 1 [hp_X]
Other brand names: Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Hahnemann Laboratories, Inc.)
Borax (by Ohm Pharma Inc.)
Borax (by Rxhomeo Private Limited D. B. a. Rxhomeo, Inc)
Borax (by Rxhomeo Private Limited D. B. a. Rxhomeo, Inc)
Borax (by Sevene Usa)
Borax (by Sevene Usa)
Borax (by Warsan Homeopathic)
Borax (by Warsan Homeopathic)
Borax 30c (by Paramesh Banerji Life Sciences Llc)
View full label-group details →
Dosage form: Pellet
Route: Oral
Prescription status: Homeopathic
Marketed in the U.S.: Since 2015
Label revision date: September 28, 2021
Manufacturer Document: Prescribing information, PDF file

Active ingredient: Sodium Borate 1 [hp_X]
Other brand names: Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Boiron)
Borax (by Hahnemann Laboratories, Inc.)
Borax (by Ohm Pharma Inc.)
Borax (by Rxhomeo Private Limited D. B. a. Rxhomeo, Inc)
Borax (by Rxhomeo Private Limited D. B. a. Rxhomeo, Inc)
Borax (by Sevene Usa)
Borax (by Sevene Usa)
Borax (by Warsan Homeopathic)
Borax (by Warsan Homeopathic)
Borax 30c (by Paramesh Banerji Life Sciences Llc)
View full label-group details →
Dosage form: Pellet
Route: Oral
Prescription status: Homeopathic
CSA schedule: Not a scheduled drug
Marketed in the U.S.: Since 2015
Label revision date: September 28, 2021
Manufacturer: Rxhomeo Private Limited d. b. a. Rxhomeo, Inc
NDC root: 15631-0084
Manufacturer Document: Prescribing information, PDF file

Packaging Info (8 NDCs)

Packaging & NDC Codes (8)

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

You may be looking for information about a specific medication, but unfortunately, the details provided do not include the drug's name, its general description, or its mechanism of action. Without this information, it's difficult to explain what the drug is or what it is used for.

If you have more specific details about the drug, such as its name or intended use, I would be happy to help you understand it better. Please feel free to share any additional information you have!

Uses

You may be prescribed this medication for a specific condition as determined by your doctor. It's important to follow their guidance on how to use it effectively.

There are no known teratogenic effects (which means it doesn't cause birth defects) or nonteratogenic effects (which refers to other types of harmful effects) associated with this medication. Always consult your healthcare provider if you have any questions or concerns about its use.

Dosage and Administration

You should take this medication by mouth, either 4 or 6 pellets, three times a day. If your doctor has provided specific instructions, be sure to follow those. For children aged 2 years and older, the dosage is half of what an adult would take, so they would take either 2 or 3 pellets three times daily.

It's important to stick to this schedule to ensure the medication works effectively. If you have any questions about the dosage or how to take it, don’t hesitate to reach out to your healthcare provider for guidance.

Warnings and Precautions

This product is intended for short-term use to help with self-limiting conditions, meaning it should only be used for issues that typically resolve on their own. If your symptoms do not improve within four days or if they worsen, it’s important to stop using the product and consult a healthcare professional for further guidance.

If you are pregnant or nursing, please seek advice from a healthcare provider before using this medication. Always keep this and all medications out of reach of children to prevent accidental ingestion. Additionally, do not use the product if the cap seal is broken or missing, and remember to close the cap tightly after each use to maintain its effectiveness.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the effects of an overdose for this medication, you should be aware of general signs that may indicate a problem. These can include unusual drowsiness, confusion, or difficulty breathing.

If you notice any of these symptoms or if you believe you have taken too much of the medication, seek medical help right away. Contact your healthcare provider or go to the nearest emergency room. It's always better to be safe and get checked out if you have concerns about an overdose.

Storage and Handling

To ensure the best performance and safety of your product, store it in a cool, dark place. This helps maintain its effectiveness and prevents any degradation that could occur from exposure to light or heat.

When handling the product, always ensure that your hands are clean to avoid contamination. If there are any specific components included with the product, make sure to follow any additional instructions provided for their use or disposal. Proper storage and handling are key to ensuring your product remains safe and effective.

Additional Information

This medication is taken orally and is intended for self-limiting conditions, meaning it should help with symptoms that typically resolve on their own. If your symptoms do not improve within four days or if they worsen, you should stop using the product and consult a healthcare professional.

If you are pregnant or nursing, it's important to seek advice from a healthcare provider before using this medication. Always keep this and all medications out of reach of children, and do not use the product if the cap seal is broken or missing. Remember to close the cap tightly after each use to ensure safety.

FAQ

What conditions is this drug used for?

This drug is used for the condition listed above or as directed by your physician.

What is the recommended dosage for adults?

Adults should take 4 or 6 Pellets by mouth, three times daily or as suggested by your physician.

What is the dosage for children?

Children 2 years and older should take half the adult dose.

How should I take this medication?

You should take this medication by mouth, three times daily or as suggested by your physician.

What should I do if my symptoms do not improve?

If your symptoms do not improve in 4 days or worsen, you should discontinue use and seek assistance from a health professional.

Is this drug safe to use during pregnancy or while nursing?

As with any drug, you should seek professional advice before taking this product if you are pregnant or nursing a baby.

How should I store this medication?

You should store this medication in a cool, dark place.

What precautions should I take with this medication?

Keep this and all medication out of reach of children, do not use if the cap seal is broken or missing, and close the cap tightly after use.

Packaging Info

This section summarizes the homeopathic presentations of Borax. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Borax.

	100 in package 100 items total	Pellet	1 [hp_X]
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Active (as of January 1, 2018) Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients sucrose
	200 in package 200 items total	Pellet	1 [hp_X]
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Active (as of January 1, 2018) Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients sucrose
	400 in package 400 items total	Pellet	1 [hp_X]
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Active (as of January 1, 2018) Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients sucrose
	750 in package 750 items total	Pellet	1 [hp_X]
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Active (as of January 1, 2018) Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients sucrose
	2500 in package 2500 items total	Pellet	1 [hp_X]
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Active (as of January 1, 2018) Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients sucrose
	12500 in package 12500 items total	Pellet	1 [hp_X]
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Active (as of January 1, 2018) Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients sucrose
	500 in package 500 items total	Pellet	1 [hp_X]
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Active (as of August 23, 2021) Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients sucrose
	1000 in package 1000 items total	Pellet	1 [hp_X]
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Active (as of August 23, 2021) Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients sucrose

Manufacturer Insert (PDF)

This file includes usage instructions and other product details provided by the manufacturer. This is not an FDA-approved drug.

View manufacturer document (PDF)

Description

Description:

This product contains BORAX HPUS 1X and higher as the active ingredient, specifically SODIUM BORATE (UNII: 91MBZ8H3QO), with a strength of SODIUM BORATE 1 hp_X. It is classified as a human over-the-counter drug and is administered orally. The inactive ingredient present is SUCROSE (UNII: C151H8M554).

The product is available in various packaging configurations, including:

NDC: 15631-0084-0: 100 units per package
NDC: 15631-0084-1: 200 units per package
NDC: 15631-0084-2: 400 units per package
NDC: 15631-0084-3: 750 units per package
NDC: 15631-0084-4: 2500 units per package
NDC: 15631-0084-5: 12500 units per package
NDC: 15631-0084-6: 500 units per package
NDC: 15631-0084-7: 1000 units per package

This product is marketed as an unapproved homeopathic drug, with a marketing start date of September 12, 2015.

Packaging & NDC

This section summarizes the homeopathic presentations of Borax. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Borax.

	100 in package 100 items total	Pellet	1 [hp_X]
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Active (as of January 1, 2018) Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients sucrose
	200 in package 200 items total	Pellet	1 [hp_X]
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Active (as of January 1, 2018) Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients sucrose
	400 in package 400 items total	Pellet	1 [hp_X]
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Active (as of January 1, 2018) Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients sucrose
	750 in package 750 items total	Pellet	1 [hp_X]
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Active (as of January 1, 2018) Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients sucrose
	2500 in package 2500 items total	Pellet	1 [hp_X]
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Active (as of January 1, 2018) Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients sucrose
	12500 in package 12500 items total	Pellet	1 [hp_X]
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Active (as of January 1, 2018) Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients sucrose
	500 in package 500 items total	Pellet	1 [hp_X]
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Active (as of August 23, 2021) Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients sucrose
	1000 in package 1000 items total	Pellet	1 [hp_X]
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Active (as of August 23, 2021) Type Type 0: Not a Combination Product Active ingredients Sodium Borate 1 [hp_X] Inactive ingredients sucrose

Manufacturer Insert (PDF)

This is the product document submitted by Rxhomeo Private Limited d. b. a. Rxhomeo, Inc for Borax. It includes information on ingredients, suggested use, and labeling language. This product is not FDA-approved.

View product insert (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the manufacturer-supplied FDA Structured Product Label (DailyMed) for Borax, retrieved February 18, 2026 by a validated AI data-extraction workflow.

All dosage forms and strengths provided by the manufacturer are listed in the Packaging & NDC Codes section above.

Homeopathic drug products are not reviewed by FDA for safety or effectiveness; information is reproduced without modification.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update: February 18, 2026

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.